The dawn of a new era: targeting the “undruggables” with antibody-based therapeutics

L Qian, X Lin, X Gao, RU Khan, JY Liao, S Du… - Chemical …, 2023 - ACS Publications
The high selectivity and affinity of antibodies toward their antigens have made them a highly
valuable tool in disease therapy, diagnosis, and basic research. A plethora of chemical and …

Glycosylation in health and disease

C Reily, TJ Stewart, MB Renfrow, J Novak - Nature Reviews Nephrology, 2019 - nature.com
The glycome describes the complete repertoire of glycoconjugates composed of
carbohydrate chains, or glycans, that are covalently linked to lipid or protein molecules …

Fc-engineering for modulated effector functions—improving antibodies for cancer treatment

R Liu, RJ Oldham, E Teal, SA Beers, MS Cragg - Antibodies, 2020 - mdpi.com
The majority of monoclonal antibody (mAb) therapeutics possess the ability to engage
innate immune effectors through interactions mediated by their fragment crystallizable (Fc) …

Progress and challenges in the design and clinical development of antibodies for cancer therapy

JC Almagro, TR Daniels-Wells… - Frontiers in …, 2018 - frontiersin.org
The remarkable progress in engineering and clinical development of therapeutic antibodies
in the last 40 years, after the seminal work by Köhler and Milstein, has led to the approval by …

Capillary electrophoresis separations of glycans

G Lu, CL Crihfield, S Gattu, LM Veltri… - Chemical …, 2018 - ACS Publications
Capillary electrophoresis has emerged as a powerful approach for carbohydrate analyses
since 2014. The method provides high resolution capable of separating carbohydrates by …

Boosting therapeutic potency of antibodies by taming Fc domain functions

TH Kang, ST Jung - Experimental & molecular medicine, 2019 - nature.com
Monoclonal antibodies (mAbs) are one of the most widely used drug platforms for infectious
diseases or cancer therapeutics because they selectively target pathogens, infectious cells …

Therapeutic antibodies: what have we learnt from targeting CD20 and where are we going?

MJE Marshall, RJ Stopforth, MS Cragg - Frontiers in immunology, 2017 - frontiersin.org
Therapeutic monoclonal antibodies (mAbs) have become one of the fastest growing classes
of drugs in recent years and are approved for the treatment of a wide range of indications …

Glycoengineering of antibodies for modulating functions

LX Wang, X Tong, C Li, JP Giddens… - Annual review of …, 2019 - annualreviews.org
Antibodies are immunoglobulins that play essential roles in immune systems. All antibodies
are glycoproteins that carry at least one or more conserved N-linked oligosaccharides (N …

G protein–coupled receptors in asthma therapy: pharmacology and drug action

SG Wendell, H Fan, C Zhang, PA Insel - Pharmacological reviews, 2020 - Elsevier
Asthma is a heterogeneous inflammatory disease of the airways that is associated with
airway hyperresponsiveness and airflow limitation. Although asthma was once simply …

Strategies to control therapeutic antibody glycosylation during bioprocessing: Synthesis and separation

E Edwards, M Livanos, A Krueger, A Dell… - Biotechnology and …, 2022 - Wiley Online Library
Glycosylation can be a critical quality attribute in biologic manufacturing. In particular, it has
implications on the half‐life, immunogenicity, and pharmacokinetics of therapeutic …